Catalysts for Teva Pharmaceuticals USA Inc
453 tracked
Feb 8, 2023
approval
FENTANYL CITRATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Jan 19, 2023
approval
NIZORAL ANTI-DANDRUFF (KETOCONAZOLE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 16, 2022
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 8, 2022
approval
FENTORA (FENTANYL CITRATE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 8, 2022
approval
ACTIQ (FENTANYL CITRATE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Nov 22, 2022
approval
FENTORA (FENTANYL CITRATE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Nov 22, 2022
approval
ACTIQ (FENTANYL CITRATE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Oct 27, 2022
approval
VIGABATRIN — FDA approval
Teva Pharmaceuticals USA Inc
→
Oct 27, 2022
approval
VIGABATRIN — FDA approval
Teva Pharmaceuticals USA Inc
→
Oct 12, 2022
approval
VIGABATRIN — FDA approval
Teva Pharmaceuticals USA Inc
→
Oct 12, 2022
approval
VIGABATRIN — FDA approval
Teva Pharmaceuticals USA Inc
→
Oct 6, 2022
approval
CLARAVIS (ISOTRETINOIN) — FDA approval
Teva Pharmaceuticals USA Inc
→
Oct 6, 2022
approval
CLARAVIS (ISOTRETINOIN) — FDA approval
Teva Pharmaceuticals USA Inc
→
Aug 23, 2022
approval
CLARAVIS (ISOTRETINOIN) — FDA approval
Teva Pharmaceuticals USA Inc
→
Aug 23, 2022
approval
CLARAVIS (ISOTRETINOIN) — FDA approval
Teva Pharmaceuticals USA Inc
→
Aug 17, 2022
approval
FENTORA (FENTANYL CITRATE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Aug 17, 2022
approval
ACTIQ (FENTANYL CITRATE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Jun 17, 2022
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Jun 17, 2022
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Jun 13, 2022
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Jun 7, 2022
approval
FINASTERIDE — FDA approval
Teva Pharmaceuticals USA Inc
→
Jun 7, 2022
approval
FINASTERIDE — FDA approval
Teva Pharmaceuticals USA Inc
→
May 13, 2022
approval
NIZORAL ANTI-DANDRUFF (KETOCONAZOLE) — FDA approval
Teva Pharmaceuticals USA Inc
→
May 4, 2022
approval
POMALIDOMIDE — FDA approval
Teva Pharmaceuticals USA Inc
→
May 3, 2022
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Mar 31, 2022
approval
OXALIPLATIN — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 15, 2021
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 15, 2021
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 15, 2021
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 3, 2021
approval
FENTORA (FENTANYL CITRATE) — FDA approval
Teva Pharmaceuticals USA Inc
→